Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of the National Cancer Institute
|
September 2, 1992
Thymopentin in Sézary syndrome
M G Bernengo, A Appino, M Bertero, et al.
Melanoma Research
|
April 1, 1993
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen
M T Fierro, M Bertero, M Novelli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
April 1, 1988
[Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients]
M G Bernengo, G C Doveil, A Appino, et al.
Journal of Neurology
|
March 15, 2005
Asymptomatic white matter ischemic lesions in a patient with pseudoxanthoma elasticum
Paolo Cerrato, M Giraudo, C Baima, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
September 1, 1986
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)]
M G Bernengo, G C Doveil, F Lisa, et al.
Dermatology (Basel, Switzerland)
|
January 1, 1995
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance
G C Doveil, M T Fierro, M Novelli, et al.
Melanoma Research
|
June 1, 1996
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot study
M G Bernengo, G C Doveil, M Bertero, et al.
Oncology
|
January 1, 1989
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma
M R Sertoli, M G Bernengo, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 1998
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features
M G Bernengo, P Quaglino, M Novelli, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of the National Cancer Institute
|
September 2, 1992
Thymopentin in Sézary syndrome
M G Bernengo, A Appino, M Bertero, et al.
Melanoma Research
|
April 1, 1993
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen
M T Fierro, M Bertero, M Novelli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
April 1, 1988
[Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients]
M G Bernengo, G C Doveil, A Appino, et al.
Journal of Neurology
|
March 15, 2005
Asymptomatic white matter ischemic lesions in a patient with pseudoxanthoma elasticum
Paolo Cerrato, M Giraudo, C Baima, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
September 1, 1986
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)]
M G Bernengo, G C Doveil, F Lisa, et al.
Dermatology (Basel, Switzerland)
|
January 1, 1995
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance
G C Doveil, M T Fierro, M Novelli, et al.
Melanoma Research
|
June 1, 1996
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot study
M G Bernengo, G C Doveil, M Bertero, et al.
Oncology
|
January 1, 1989
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma
M R Sertoli, M G Bernengo, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 1998
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features
M G Bernengo, P Quaglino, M Novelli, et al.
Page
of 3